BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31706886)

  • 21. Multicentre, randomised, blinded, control trial of drug-eluting balloon vs Sham in recurrent native dialysis fistula stenoses.
    Swinnen JJ; Hitos K; Kairaitis L; Gruenewald S; Larcos G; Farlow D; Huber D; Cassorla G; Leo C; Villalba LM; Allen R; Niknam F; Burgess D
    J Vasc Access; 2019 May; 20(3):260-269. PubMed ID: 30227772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-Coated Balloon Angioplasty for Dysfunctional Arteriovenous Hemodialysis Fistulae: A Randomized Controlled Trial.
    Zhao Y; Wang P; Wang Y; Zhang L; Zhao Y; Li H; He Q; Liu H; Luo J; Jia X; Yu Z; Guo W; Zhang L
    Clin J Am Soc Nephrol; 2024 Mar; 19(3):336-344. PubMed ID: 38191561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Drug-Coated Balloons in Dysfunctional Arteriovenous Dialysis Access Treatment: The Effect of Consecutive Treatments on Lesion Patency.
    Kitrou PM; Katsanos K; Spyridonidis I; Theofanis M; Papachristou E; Papadoulas S; Karnabatidis D
    J Vasc Interv Radiol; 2019 Feb; 30(2):212-216. PubMed ID: 30717952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized clinical trial of cutting balloon angioplasty versus high-pressure balloon angioplasty in hemodialysis arteriovenous fistula stenoses resistant to conventional balloon angioplasty.
    Aftab SA; Tay KH; Irani FG; Gong Lo RH; Gogna A; Haaland B; Tan SG; Chng SP; Pasupathy S; Choong HL; Tan BS
    J Vasc Interv Radiol; 2014 Feb; 25(2):190-8. PubMed ID: 24315548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
    Tepe G; Schroeder H; Albrecht T; Reimer P; Diehm N; Baeriswyl JL; Brechtel K; Speck U; Zeller T
    J Endovasc Ther; 2020 Apr; 27(2):276-286. PubMed ID: 32096451
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas.
    Lookstein RA; Haruguchi H; Ouriel K; Weinberg I; Lei L; Cihlar S; Holden A;
    N Engl J Med; 2020 Aug; 383(8):733-742. PubMed ID: 32813949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of 200 Chinese Patients With Severe Femoropopliteal Lesions: 24-Month Results of AcoArt I.
    Xu Y; Jia X; Zhang J; Zhuang B; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2347-2353. PubMed ID: 30448170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-coated balloon angioplasty for dialysis access fistula stenosis.
    Boitet A; Massy ZA; Goeau-Brissonniere O; Javerliat I; Coggia M; Coscas R
    Semin Vasc Surg; 2016 Dec; 29(4):178-185. PubMed ID: 28779784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
    Steiner S; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
    JACC Cardiovasc Interv; 2018 May; 11(10):934-941. PubMed ID: 29730375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-Coated Versus Plain Balloon Angioplasty In Arteriovenous Fistulas: A Randomized, Controlled Study With 1-Year Follow-Up (The Drecorest Ii-Study).
    Björkman P; Weselius EM; Kokkonen T; Rauta V; Albäck A; Venermo M
    Scand J Surg; 2019 Mar; 108(1):61-66. PubMed ID: 30182815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective comparison analysis of results of drug-coated balloon versus plain balloon angioplasty in treatment of juxta-anastomotic de novo stenosis of radiocephalic arteriovenous fistulas.
    Kocaaslan C; Oztekin A; Bademci MS; Denli Yalvac ES; Bulut N; Aydin E
    J Vasc Access; 2020 Sep; 21(5):596-601. PubMed ID: 31825294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Clinical Effectiveness and Safety of Drug-Coated Balloons versus Percutaneous Transluminal Angioplasty in Arteriovenous Fistulae: A Review of Systematic Reviews and Updated Meta-Analysis.
    Lee H; Choi H; Han E; Kim YJ
    J Vasc Interv Radiol; 2024 Jul; 35(7):949-962.e13. PubMed ID: 38554948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-coated balloons versus conventional percutaneous transluminal angioplasty for treatment-naïve dysfunctional arteriovenous fistulas.: A 10-year single center retrospective study.
    AlQubaisi A; Arabi M; AlZahrani Y; Bashir O
    Saudi Med J; 2024 Jul; 45(7):741-744. PubMed ID: 38955442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
    Schroeder H; Werner M; Meyer DR; Reimer P; Krüger K; Jaff MR; Brodmann M;
    Circulation; 2017 Jun; 135(23):2227-2236. PubMed ID: 28424223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.
    Bausback Y; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
    J Endovasc Ther; 2017 Aug; 24(4):459-467. PubMed ID: 28558502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-coated balloon angioplasty in failing haemodialysis arteriovenous shunts: 12-month outcomes in 200 patients from the Aperto Italian registry.
    Tozzi M; Franchin M; Savio D; Comelli S; Di Maggio L; Carbonari L; Ebrahimi R; Fontana F; Piacentino F; Cervarolo MC; Palermo V; Piffaretti G
    J Vasc Access; 2019 Nov; 20(6):733-739. PubMed ID: 31130061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-Coated Balloon Angioplasty in Hemodialysis Circuits: A Systematic Review and Meta-Analysis.
    Kennedy SA; Mafeld S; Baerlocher MO; Jaberi A; Rajan DK
    J Vasc Interv Radiol; 2019 Apr; 30(4):483-494.e1. PubMed ID: 30857987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
    Krishnan P; Faries P; Niazi K; Jain A; Sachar R; Bachinsky WB; Cardenas J; Werner M; Brodmann M; Mustapha JA; Mena-Hurtado C; Jaff MR; Holden AH; Lyden SP
    Circulation; 2017 Sep; 136(12):1102-1113. PubMed ID: 28729250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-Center Prospective Pilot Study of Sirolimus Drug-Coated Balloon Angioplasty in Maintaining the Patency of Thrombosed Arteriovenous Graft.
    Tan CW; Tan RY; Pang SC; Tng ARK; Tang TY; Zhuang KD; Chua JME; Tay KH; Chong TT; Tan CS
    J Vasc Interv Radiol; 2021 Mar; 32(3):369-375. PubMed ID: 33334667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
    J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.